GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vaso Corporation (OTCPK:VASO) » Definitions » Cyclically Adjusted Price-to-FCF

Vaso (VASO) Cyclically Adjusted Price-to-FCF : 11.89 (As of Jun. 06, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Vaso Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), Vaso's current share price is $0.23775. Vaso's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.02. Vaso's Cyclically Adjusted Price-to-FCF for today is 11.89.

The historical rank and industry rank for Vaso's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

VASO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 1   Med: 6   Max: 17.25
Current: 13.09

During the past years, Vaso's highest Cyclically Adjusted Price-to-FCF was 17.25. The lowest was 1.00. And the median was 6.00.

VASO's Cyclically Adjusted Price-to-FCF is ranked better than
70.45% of 176 companies
in the Healthcare Providers & Services industry
Industry Median: 23.74 vs VASO: 13.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Vaso's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-0.009. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vaso Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Vaso's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaso Cyclically Adjusted Price-to-FCF Chart

Vaso Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.94 5.83 3.16 8.85 13.02

Vaso Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.52 11.28 14.21 13.02 15.47

Competitive Comparison of Vaso's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, Vaso's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaso's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vaso's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vaso's Cyclically Adjusted Price-to-FCF falls into.



Vaso Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Vaso's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=0.23775/0.02
=11.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaso's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Vaso's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.009/131.7762*131.7762
=-0.009

Current CPI (Mar. 2024) = 131.7762.

Vaso Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.012 100.560 -0.016
201409 0.001 100.428 0.001
201412 -0.001 99.070 -0.001
201503 0.040 99.621 0.053
201506 0.003 100.684 0.004
201509 -0.009 100.392 -0.012
201512 0.002 99.792 0.003
201603 0.010 100.470 0.013
201606 0.008 101.688 0.010
201609 -0.003 101.861 -0.004
201612 0.006 101.863 0.008
201703 -0.001 102.862 -0.001
201706 0.001 103.349 0.001
201709 -0.007 104.136 -0.009
201712 0.002 104.011 0.003
201803 -0.005 105.290 -0.006
201806 -0.015 106.317 -0.019
201809 -0.003 106.507 -0.004
201812 -0.002 105.998 -0.002
201903 -0.007 107.251 -0.009
201906 -0.012 108.070 -0.015
201909 0.001 108.329 0.001
201912 0.002 108.420 0.002
202003 0.037 108.902 0.045
202006 -0.015 108.767 -0.018
202009 0.003 109.815 0.004
202012 0.005 109.897 0.006
202103 0.032 111.754 0.038
202106 0.000 114.631 0.000
202109 -0.002 115.734 -0.002
202112 0.013 117.630 0.015
202203 -0.005 121.301 -0.005
202206 0.059 125.017 0.062
202209 0.016 125.227 0.017
202212 0.009 125.222 0.009
202303 -0.012 127.348 -0.012
202306 0.044 128.729 0.045
202309 0.004 129.860 0.004
202312 -0.010 129.419 -0.010
202403 -0.009 131.776 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vaso  (OTCPK:VASO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Vaso Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Vaso's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaso (VASO) Business Description

Traded in Other Exchanges
N/A
Address
137 Commercial Street, Unit 200, Plainview, NY, USA, 11803
Vaso Corporation is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. It generates maximum revenue from the IT segment. IT segment focuses on healthcare IT and managed network technology services.
Executives
Leon Dembo director 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Janey Moen director 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Jun Ma director C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Edgar Rios director 1650 TYSONS BOULEVARD, SUITE 900, MCLEAN VA 22102
Michael Beecher officer: Chief Financial Officer C/O DIRECT INSITE CORP, 80 ORVILLE DRIVE, BOHEMIA NY 11716
Joshua Markowitz director 3131 PRINCETON PIKE, BLDG. 3D, SUITE 200, LAWRENCEVILLE NJ 08648
Jonathan P Newton officer: Vice Pres Finance & Controller 152 RICHMOND AVENUE, AMITYVILLE NY 11701
Peter C Castle director C/O NETWOLVES CORP, 4002 EISENHOWER BLVD, TEMPA FL 33634
David H Lieberman director 3061 INDUSTRY DR, LANCASTER PA 17603
Behnam Movaseghi director C/O KERNS MANUFACTURING CORPORATION, 37-14 29TH STREET, LONG ISLAND CITY NY 11101
Nelson Randall Hill officer: Senior Vice President 3880 EAST COUNTY HIGHWAY 30A, UNIT 201, SANTA ROSA BEACH FL 24159
William Edward Dempsey director 52 PARK AVENUE, SANDYMOUNT L2 DUBLIN 4
David Tarachand Singh officer: Chief Financial Officer C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Joseph Giacalone director
Derek Enlander director 88C UNION AVENUE, CENTER MORICHES NY 11934